
Arbutus Biopharma Corporation
Get Full AccessDescription
- Arbutus Biopharma Corporation (NASDAQ:ABUS) is a publicly-traded biopharmaceutical company dedicated to discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B infection, a disease of the liver caused by hepatitis B virus (HBV). We are developing a portfolio of drug candidates with multiple mechanisms of action that we believe will result in a combination therapy that will transform the HBV treatment landscape and cure hepatitis B virus disease. In addition to our HBV Assets, we are developing a pipeline of programs that leverage our expertise in RNA interference (RNAi) therapeutics and our Lipid Nanoparticle (LNP) technology.
-
Headquarters:701 Veterans Circle , Warminster, Pennsylvania, United States
More -
Phone Number: +1 604-419-3200
-
Website: https://www.arbutusbio.com
-
Employees:83
-
Revenue:$100 - 250M
-
Legal Name:Arbutus Biopharma Corporation
-
Arbutus Biopharma Corporation's Social Media
-
Is this data correct?
-
| NAICS Code: 325412 |
Show More
Frequently Asked Questions regarding Arbutus Biopharma Corporation
-
Where are Arbutus Biopharma Corporation's Headquarters?
Arbutus Biopharma Corporation's Headquarters are in 701 Veterans Circle ,Warminster,Pennsylvania,United States
-
What is Arbutus Biopharma Corporation's phone number?
Arbutus Biopharma Corporation's phone number is +1 604-419-3200
-
What is Arbutus Biopharma Corporation's official website?
Arbutus Biopharma Corporation's official website is https://www.arbutusbio.com
-
What is Arbutus Biopharma Corporation's Revenue?
Arbutus Biopharma Corporation's revenue is $100 - 250M
-
What is Arbutus Biopharma Corporation's NAICS code?
Arbutus Biopharma Corporation's NAICS code is 325412
-
How many employees are working in Arbutus Biopharma Corporation
Arbutus Biopharma Corporation has 83 employees
-
What is Arbutus Biopharma Corporation's Industry?
Arbutus Biopharma Corporation is in the industry of Biotechnology
-
Who is Arbutus Biopharma Corporation's CEO?
Arbutus Biopharma Corporation's CEO is William Collier